JP2004210715A5 - - Google Patents

Download PDF

Info

Publication number
JP2004210715A5
JP2004210715A5 JP2002382121A JP2002382121A JP2004210715A5 JP 2004210715 A5 JP2004210715 A5 JP 2004210715A5 JP 2002382121 A JP2002382121 A JP 2002382121A JP 2002382121 A JP2002382121 A JP 2002382121A JP 2004210715 A5 JP2004210715 A5 JP 2004210715A5
Authority
JP
Japan
Prior art keywords
osteoclast formation
formation inhibitor
sulfated glycosaminoglycan
inhibitor according
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002382121A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004210715A (ja
JP4567942B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002382121A priority Critical patent/JP4567942B2/ja
Priority claimed from JP2002382121A external-priority patent/JP4567942B2/ja
Publication of JP2004210715A publication Critical patent/JP2004210715A/ja
Publication of JP2004210715A5 publication Critical patent/JP2004210715A5/ja
Application granted granted Critical
Publication of JP4567942B2 publication Critical patent/JP4567942B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002382121A 2002-12-27 2002-12-27 破骨細胞形成抑制剤 Expired - Fee Related JP4567942B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002382121A JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002382121A JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Publications (3)

Publication Number Publication Date
JP2004210715A JP2004210715A (ja) 2004-07-29
JP2004210715A5 true JP2004210715A5 (it) 2006-02-09
JP4567942B2 JP4567942B2 (ja) 2010-10-27

Family

ID=32817794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002382121A Expired - Fee Related JP4567942B2 (ja) 2002-12-27 2002-12-27 破骨細胞形成抑制剤

Country Status (1)

Country Link
JP (1) JP4567942B2 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401069D0 (sv) 2004-04-26 2004-04-26 Anamar Medical Ab Use of Compounds for the Treatment of Diseases and Conditions
JPWO2006068146A1 (ja) * 2004-12-20 2008-06-12 生化学工業株式会社 新規コンドロイチン硫酸画分
JP5153324B2 (ja) * 2005-03-14 2013-02-27 生化学工業株式会社 硬組織形成促進剤
JP5051999B2 (ja) * 2005-11-17 2012-10-17 国立大学法人名古屋大学 炎症性骨・軟骨疾患の処置剤
JP2007224286A (ja) * 2006-01-25 2007-09-06 Tottori Univ 生体組織からの多糖類の取得方法
JP5099617B2 (ja) * 2006-03-16 2012-12-19 国立大学法人東京農工大学 歯周病予防・治療剤
JP5063940B2 (ja) * 2006-06-20 2012-10-31 生化学工業株式会社 コンドロイチン硫酸・鉄コロイド製剤及びその製造方法
WO2008102568A1 (ja) * 2007-02-22 2008-08-28 Pg Research Co., Ltd. 骨軟骨形成促進剤
AU2010328726B2 (en) * 2009-12-09 2017-01-19 Agency For Science, Technology And Research Glycosaminoglycan mixtures
DK2707396T3 (en) * 2011-05-12 2019-01-28 Gnosis Spa Biotechnological sulfated chondroitin sulfate at position 4 or 6 on the same polysaccharide chain and process for its preparation
CN105924544B (zh) * 2016-05-16 2018-03-09 山东大学 一种高硫酸化硫酸软骨素及其制备方法与应用

Similar Documents

Publication Publication Date Title
ECSP055722A (es) Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
JP2004210715A5 (it)
Draget et al. Ionic and acid gel formation of epimerised alginates; the effect of AlgE4
Alban et al. Partial synthetic glucan sulfates as potential new antithrombotics: a review
AU2001269478B2 (en) Hyaluronic acid oligosaccharide fractions and drugs containing the same
AU2003275958A1 (en) Muteins of tear lipocalin
DK0928206T3 (da) Hydrokolloid sårgel
BR0113663A (pt) Composições de pelìcula de pectina
DE69518333T2 (de) Polysaccharide mit hohem anteil an iduronsäure
Barbucci et al. Immobilisation of sulphated hyaluronan for improved biocompatibility
JP2011513034A5 (it)
CA2637753A1 (en) Fabric care compositions comprising cationic starch
MX2009001203A (es) Muteinas de lipocalina lacrimosa y metodos para obtener las mismas.
Arlov et al. The impact of chain length and flexibility in the interaction between sulfated alginates and HGF and FGF-2
Przybylski et al. HABA-based ionic liquid matrices for UV-MALDI-MS analysis of heparin and heparan sulfate oligosaccharides
Linhardt et al. Low molecular weight dermatan sulfate as an antithrombotic agent structure-activity relationship studies
PL375693A1 (en) Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups
Jacobsson et al. Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells.
TW200704403A (en) Dilution resistant viscoelastic compositions
KR102007554B1 (ko) N-탈황화된 글리코스아미노글리칸 유도체 및 약물로서의 용도
TW200745154A (en) Oligosaccharides derived from fucoidan
PL375088A1 (en) Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
JP2002145779A5 (it)
ITMI20132116A1 (it) Associazione di glicosamminoglicani e ciclodestrine
WO2005010051A3 (fr) Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant